Metformin tablet formulations
Pro Research Analysisby 
Searched over 200M research papers
Immediate Release Metformin Tablet Formulations
Immediate release (IR) metformin tablets are designed for rapid onset of action, which is important for managing blood glucose levels in type 2 diabetes. Studies show that using superdisintegrants like croscarmellose sodium and sodium starch glycolate can significantly enhance drug release and reduce disintegration time. For example, formulations with these superdisintegrants achieved drug release rates of 90–99% and rapid disintegration, making them effective for immediate therapeutic needs 127. The choice and concentration of superdisintegrants are critical, as higher amounts can further improve dissolution and disintegration times 27. Additionally, excipients like mannitol can improve mouth feel and tablet performance in orodispersible formulations .
Orodispersible and Oral Dissolving Metformin Tablets
Orodispersible and oral dissolving tablets (ODTs) of metformin are developed to improve patient compliance, especially for those who have difficulty swallowing. These formulations use direct compression methods and include superdisintegrants and excipients such as MCC Burst and Neusillin US2 to optimize tablet properties. Optimized ODTs can achieve rapid disintegration (as low as 7.8 seconds) and high drug release (up to 99.65% within 30 minutes) 210. Most ODT formulations release more than 82% of the drug within 3 minutes, making them suitable for fast therapeutic action .
Sustained Release and Modified Release Metformin Tablets
Sustained release (SR) and modified release (MR) metformin tablets are designed to maintain therapeutic drug levels over an extended period, reducing dosing frequency and improving patient adherence. Hydrophilic polymers such as hydroxypropyl methylcellulose (HPMC) and sodium carboxymethyl cellulose are commonly used to control drug release. High concentrations of HPMC K100 can prolong drug release up to 6 hours, while specific formulations can achieve up to 72.72% release in 6 hours, providing a more gradual and sustained effect 35. Combining HPMC K100M with polyvinyl pyrrolidone K30 further optimizes the release profile, supporting once-daily dosing and minimizing side effects .
Natural polymers like sodium alginate and pectin are also effective in sustaining drug release. Increasing the amount of these polymers slows down the release, with some formulations achieving over 93% release in 12 hours, primarily through diffusion and erosion mechanisms .
Bilayer and Combination Metformin Tablet Formulations
Bilayer tablets combine metformin with other antidiabetic agents, such as gliclazide or vildagliptin, to provide both immediate and sustained release effects. In these formulations, metformin is typically included in the sustained release layer, while the other drug is in the immediate release layer. The use of mucoadhesive polymers like carbopol 971 and various grades of HPMC can enhance mucoadhesion and control drug release, with some formulations maintaining drug release for up to 8 hours . Combination tablets are optimized for hardness, friability, and dissolution to ensure effective delivery of both drugs .
Gastroretentive and Floating Metformin Tablets
Gastroretentive floating tablets are designed to prolong the retention of metformin in the upper gastrointestinal tract, where its absorption is optimal. These tablets use polymers such as guar gum, k-carrageenan, and HPMC K100, along with gas-generating agents like sodium bicarbonate and citric acid, to achieve buoyancy and sustained drug release. Optimized formulations can float for up to 12 hours and provide continuous drug release, following non-Fickian diffusion mechanisms .
Conclusion
Metformin tablet formulations are highly versatile, with options for immediate, orodispersible, sustained, bilayer, and gastroretentive delivery. The choice of formulation depends on therapeutic goals, patient needs, and desired release profiles. Superdisintegrants and hydrophilic polymers play key roles in optimizing drug release and tablet performance across these different formulations 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic